U.S. market Closed. Opens in 17 hours 11 minutes

VINC | Vincerx Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue915.00K939.00K340.00K173.00K173.00K
Gross Profit-915.00K-939.00K-340.00K-173.00K-173.00K
Operating Expenses41.69M71.11M62.66M10.71M45.00K
Selling, General & Admin13.64M18.95M22.57M3.60M45.00K
Research & Development28.06M52.15M40.08M7.12MN/A
Other Operating ExpensesN/A1.24M-8.00K-8.00KN/A
Operating Income-42.61M-73.57M-62.66M-10.71M-45.00K
Other Expenses / Income2.45M8.21M23.35M-8.00K54.27K
Before Tax Income-40.16M-65.37M-39.31M-10.72M-45.00K
Income Tax ExpensesN/A-8.21M-23.70M8.00K-54.00
Net Income-40.16M-57.16M-15.61M-10.73M-45.00K
Interest ExpensesN/A-8.21MN/A8.00KN/A
Basic Shares Outstanding21.30M21.03M17.18M13.98M5.20M
Diluted Shares Outstanding21.30M21.03M17.18M13.98M5.20M
EBITDA-41.69M-74.94M-86.01M-10.71M-45.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-40.16M-73.57M-39.31M-10.71M-45.05K
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙